1. Home
  2. GILD vs STX Comparison

GILD vs STX Comparison

Compare GILD & STX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gilead Sciences Inc.

GILD

Gilead Sciences Inc.

HOLD

Current Price

$125.63

Market Cap

155.3B

Sector

Health Care

ML Signal

HOLD

Logo Seagate Technology Holdings PLC (Ireland)

STX

Seagate Technology Holdings PLC (Ireland)

HOLD

Current Price

$971.13

Market Cap

182.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GILD
STX
Founded
1987
1978
Country
United States
Singapore
Employees
17000
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
155.3B
182.2B
IPO Year
2003
2002

Fundamental Metrics

Financial Performance
Metric
GILD
STX
Price
$125.63
$971.13
Analyst Decision
Strong Buy
Buy
Analyst Count
18
21
Target Price
$148.39
$604.14
AVG Volume (30 Days)
7.6M
3.4M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
2.55%
0.46%
EPS Growth
1684.21
328.48
EPS
1.61
8.29
Revenue
$24,689,000,000.00
$7,384,000,000.00
Revenue This Year
$4.68
$27.73
Revenue Next Year
$6.04
$25.06
P/E Ratio
$77.67
$125.31
Revenue Growth
9.98
N/A
52 Week Low
$107.75
$138.31
52 Week High
$157.29
$1,145.00

Technical Indicators

Market Signals
Indicator
GILD
STX
Relative Strength Index (RSI) 43.53 56.58
Support Level $116.55 $801.89
Resistance Level $126.46 N/A
Average True Range (ATR) 3.48 65.99
MACD 0.05 1.91
Stochastic Oscillator 39.82 48.49

Price Performance

Historical Comparison
GILD
STX

About GILD Gilead Sciences Inc.

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

About STX Seagate Technology Holdings PLC (Ireland)

Seagate Technology is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.

Share on Social Networks: